Transgenic activation of the kallikrein‐kinin system inhibits intramyocardial inflammation, endothelial dysfunction, and oxidative stress in experimental diabetic cardiomyopathy-Reference-Cited by-同舟云学术

Transgenic activation of the kallikrein‐kinin system inhibits intramyocardial inflammation, endothelial dysfunction, and oxidative stress in experimental diabetic cardiomyopathy

Published:2005-08-29 Issue:14 Volume:19 Page:2057-2059
ISSN:0892-6638
Container-title:The FASEB Journal
language:en
Short-container-title:FASEB j.

Author:

Tschöpe Carsten¹,Walther Thomas¹,Escher Felicitas¹,Spillmann Frank¹,Du Jing¹,Altmann Christine¹,Schimke Ingolf²,Bader Michael³,Sanchez‐Ferrer Carlos F.⁴,Schultheiss Heinz‐Peter¹,Noutsias And Michel¹

Affiliation:

1. Department of Cardiology and PneumonologyCharité ‐ University Medicine Berlin Campus Benjamin Franklin Germany

2. Department of Cardiology and PneumonologyCharité ‐ University Medicine Berlin Campus Mitte Germany

3. Max‐Delbrück‐Center for Molecular Medicine Berlin Germany

4. Department of Pharmacology and TherapeuticsFaculty of MedicineAutonomous University of Madrid Spain

Funder

Deutsche Forschungsgemeinschaft

Publisher

Wiley

Subject

Genetics,Molecular Biology,Biochemistry,Biotechnology

Link